Directs Department of Human Services to provide reimbursements for transportation expenses incurred on behalf of foster child if expenses are related to child's continuing participation in extracurricular activities child engaged in prior to child's placement in foster home or child-caring agency.
Sen. Sara Gelser Blouin
Sponsored bills
Designates April of each year as Arab-American Heritage Month.
Allows Oregon Liquor Control Commission to enter into interstate agreements with agencies of other states for purpose of ensuring multistate enforcement of standards for wine consistent with standards of state where wine was produced.
Appropriates moneys to Oregon Department of Administrative Services to increase size and diversity of group of court appointed special advocates.
Directs Governor ] Department of Human Services to provide staff support , including full-time equivalent policy analyst, for Governor's Child Foster Care Advisory Commission. Increases number of members on commission from 11 to 13. Modifies commission membership requirements. Directs Chief Justice of Supreme Court to appoint any member of commission who is representative of Judicial Department. Appropriates moneys to commission for compensation and expense reimbursement for commission members.
Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of ] amount of money spent on patient assistance programs , and ] information on financial assistance provided to pharmacies, government agencies and advocacy organizations and total amount of financial incentives paid to each pharmacy benefit manager . Excludes proprietary information from disclosure on department's website. ] Exempts from public disclosure information reported to department until department posts to website all information reported by manufacturer. Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. Requires insurers to post specified information regarding formulary, tiers and costs for small employer and individual health benefit plans to insurer's website. Requires 60-day advance notice to department and to enrollees adversely affected by change in formulary. Requires insurer and allows pharmacy to notify insured that if cash ] retail price for drug is less than insured's cost-share ] out-of-pocket cost for drug using pharmacy benefit , insured may pay cash ] retail price and expense must be counted ] if requested by enrollee, insurer must count cost toward deductible or out-of-pocket maximum. Requires State Board of Pharmacy to prescribe by rule notice of enrollee's rights for distribution to pharmacy customers and to translate notice into multiple languages. Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers ] report to Oregon Health Authority information regarding 50 most prescribed drugs and 50 most expensive drugs prescribed by provider . Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost. Requires patient advocacy organization with budget ] annual gross receipts exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority ] specified information regarding funding received from participants in pharmaceutical supply chain. Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies. Requires insurers to include with rate filing certified statement regarding insurers' use of rebates. Requires drug advertisement to disclose wholesale price of drug. ] Modifies responsibilities of Task Force on Fair Pricing of Prescription Drugs and requires report of findings, by September 15, 2020, to interim committees of Legislative Assembly related to health. Modifies reporting to department by insurers about costly drugs reimbursed by health benefit plans. Requires pharmaceutical manufacturers that register with State Board of Pharmacy to also register with department. Requires department to adopt registration fee based on reasonable cost to department to administer specified provisions.
Modifies juvenile code to prohibit placement of children and wards taken into protective custody in detention facilities. Declares emergency, effective on passage.
Authorizes recognized student government of community college or public university, or member of recognized student government, to make statement or issue resolution to promote or oppose gathering of signatures on initiative or referendum petition or adoption of ballot measure. Takes effect on 91st day following adjournment sine die. .
Prohibits long term care facilities, residential facilities, adult foster homes, child care facilities, child-caring agencies, foster homes, youth care centers, youth offender foster homes or other entities that are licensed, certified or registered to provide care to children, youth, individuals with disabilities or older adults from interfering with good faith disclosure of information by employees or volunteers about abuse or mistreatment of individuals cared for by entity, violations of state or federal laws or other practice that threatens health and safety of individuals cared for by entity, to regulatory agencies, law enforcement authorities, persons acting on behalf of individual and other specified individuals. Makes interfering with disclosure of information specified in Act unlawful employment practice.
Creates civil cause of action against person who knowingly summons police officer for reason other than suspected criminal activity ] with intent to cause specified harm.